We’ve recently updated our valuation analysis.

Context Therapeutics Valuation

Is CNTX undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CNTX?

Other financial metrics that can be useful for relative valuation.

CNTX key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenuen/a
Enterprise Value/EBITDAn/a
PEG Ration/a

Price to Book Ratio vs Peers

How does CNTX's PB Ratio compare to its peers?

CNTX PB Ratio vs Peers
The above table shows the PB ratio for CNTX vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPBEstimated GrowthMarket Cap
Peer Average2.4x
ITRM Iterum Therapeutics
0.5x-19.1%US$19.8m
JUVA.F Juva Life
1.9xn/aUS$20.1m
ONTX Onconova Therapeutics
0.5x-17.7%US$18.4m
JAGX Jaguar Health
6.9x50.5%US$18.7m
CNTX Context Therapeutics
0.4x-34.9%US$17.7m

Price-To-Book vs Peers: CNTX is good value based on its Price-To-Book Ratio (0.4x) compared to the peer average (2.4x).


Price to Earnings Ratio vs Industry

How does CNTX's PE Ratio compare vs other companies in the US Pharmaceuticals Industry?

Price-To-Book vs Industry: CNTX is good value based on its Price-To-Book Ratio (0.4x) compared to the US Pharmaceuticals industry average (1.7x)


Price to Book Ratio vs Fair Ratio

What is CNTX's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CNTX PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio0.4x
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate CNTX's Price-To-Book Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of CNTX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate CNTX's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate CNTX's fair value for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies